Treprostinil

Treprostinil

CAT N°: 10162
Price:

146.00 124.10

Primary pulmonary hypertension (PPH) is a condition of unknown cause that is characterized by increasing pulmonary arterial and vascular resistance. Treprostinil is a stable analog of prostacyclin (Item No. 18220) that is used clinically for the treatment of PPH under the trade name Remodulin™. The structural modifications in treprostinil compared to prostacyclin increase the plasma half-life from 2 minutes to 34 and 85 minutes for intravenous and subcutaneous infusion of the drug, respectively.{13285} In addition to treprostinil’s direct vasodilatory effects, it also inhibits inflammatory cytokine (TNF?, IL-1?, IL-6, GM-CF) production by human alveolar macrophages in the sub-micromolar range by preventing NF-?B translocation to the nucleus.{12665}

We also advise you